Ciprofloxacin And Dexamethasone
Product Images NDC 67296-1888

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin And Dexamethasone (NDC 67296-1888). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-ciprofoxacin-structure (Spl Ciprofloxacin Structure)

Spl-ciprofoxacin-structure (Spl Ciprofloxacin Structure)
Chemical structure diagram showing the molecular formula of ciprofloxacin hydrochloride monohydrate, one of the active ingredients in Ciprofloxacin and dexamethasone by RedPharm Drug.*
FDA Label Image

Spl-dexamethasone-structure (Spl Dexamethasone Structure)

Spl-dexamethasone-structure (Spl Dexamethasone Structure)
Chemical structure of dexamethasone as part of Ciprofloxacin and dexamethasone drug product labeled by RedPharm Drug. The diagram shows the molecular arrangement of atoms and bonds in the dexamethasone molecule.*
FDA Label Image

Spl-fig-a (Spl Figure A)

Spl-fig-a (Spl Figure A)
An instructional illustration showing a hand holding a small bottle with a dropper tip, while the other hand is positioned to receive drops from the bottle. This diagram suggests the application of a liquid medication, likely an eye or ear drop.*
FDA Label Image

Spl-fig-b (Spl Figure B)

Spl-fig-b (Spl Figure B)
Illustration showing a person lying on their side with their head resting on a flat surface, suggesting a position possibly related to administration of an ear or eye product.*
FDA Label Image

Spl-fig-c (Spl Figure C)

Spl-fig-c (Spl Figure C)
An instructional line drawing showing a person administering ear drops. The illustration features fingers holding an ear drop bottle above an ear canal, with a drop about to fall into the ear. This diagram helps demonstrate the proper technique for using ear drops.*
FDA Label Image

Spl-fig-e (Spl Figure E)

Spl-fig-e (Spl Figure E)
An instructional illustration showing three sequential steps on ear manipulation. The first image shows a hand positioning the ear. The second image demonstrates pulling the ear upward. The third image shows pulling the ear backward, likely to aid in administering ear drops or medication.*
FDA Label Image

Spl-ifu-fig-a (Spl Ifu Fig A)

Spl-ifu-fig-a (Spl Ifu Fig A)
An instructional illustration showing a close-up of hands being washed under running water, demonstrating proper hand hygiene technique.*
FDA Label Image

Spl-label (Spl Label)

Spl-label (Spl Label)
Label for Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension USP, topical ear suspension in a 7.5 mL container. The label includes usage instructions, active and inactive ingredients, storage conditions, Rx only designation, and lists Sun Pharmaceutical Ind. and Sun Pharmaceutical Medicare Ltd. as distributor and manufacturer respectively.*
FDA Label Image

Spl-showbox (Spl Showbox)

Spl-showbox (Spl Showbox)
Label for Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension USP, an ear drop solution. The label states it is for topical use in the ear only, with a volume of 7.5 mL and marked Rx only. Active ingredients and inactives are listed with storage instructions. The label includes the manufacturer and distributor information along with a barcode and the Sun Pharma logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.